Sio Gene Therapies Inc
(SIOX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Operating Expenses | 21,196 | 11,917 | 12,209 | 10,605 | 9,549 |
| Operating Income | -21,196 | -11,917 | -12,209 | -10,605 | -9,549 |
| Interest Expense | 0 | 0 | 1 | 1 | 1 |
| Other Income | -41 | 19 | 8,971 | -98 | -580 |
| Pre-tax Income | -21,237 | -11,898 | -3,239 | -10,704 | -10,130 |
| Income Tax | N/A | -28 | 92 | -188 | -146 |
| Net Income Continuous | -21,237 | -11,870 | -3,331 | -10,516 | -9,984 |
| Net Income | $-21,237 | $-11,870 | $-3,331 | $-10,516 | $-9,984 |
| EPS Basic Total Ops | -0.29 | -0.16 | -0.01 | -0.20 | -0.21 |
| EPS Basic Continuous Ops | -0.29 | -0.16 | -0.01 | -0.20 | -0.21 |
| EPS Diluted Total Ops | -0.29 | -0.16 | -0.01 | -0.20 | -0.21 |
| EPS Diluted Continuous Ops | -0.29 | -0.16 | -0.01 | -0.20 | -0.21 |
| EPS Diluted Before Non-Recurring Items | -0.29 | -0.16 | -0.19 | N/A | N/A |
| EBITDA(a) | $-21,184 | $-11,807 | $-11,920 | $-9,969 | $-8,500 |